• Synthetic Viability with ERCC1 Deficiency in Lung Cancer Rep

  2026-05-14

  Heyza et al. demonstrate that ERCC1-deficient lung cancer cells exhibit synthetic viability in response to interstrand crosslinking agents, modulated by p53 status. These findings reshape the interpretation of ERCC1 as a platinum-based chemotherapy biomarker and underscore the interplay between DNA repair pathways and cell fate after genotoxic stress.

• Neurotensin: Precision Neurotensin Receptor 1 Activator for

  2026-05-13

  Neurotensin (CAS 39379-15-2) from APExBIO empowers researchers to dissect GPCR trafficking mechanisms and miRNA regulation in gastrointestinal models with unmatched specificity and purity. This article connects advanced fluorescence-based workflows with robust troubleshooting strategies, translating recent spectral interference breakthroughs into reproducible, high-impact experiments.

• Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea): Mechanisms

  2026-05-13

  Diuron, a high-purity phenylurea herbicide, acts as a photosynthesis inhibitor and is increasingly studied for its nephrotoxic effects. Its mechanism involves photosystem II inhibition in plants and JAK2/STAT1 pathway activation in mammalian renal models. Recent network toxicology and experimental studies clarify its environmental and biological risks.

• Perphenazine: Bridging Dopamine Antagonism and Host-Directed

  2026-05-12

  Explore how Perphenazine, a dopamine D2 receptor antagonist, is shaping advanced neuropharmacology and host-pathogen research. This thought-leadership article integrates mechanistic insights, recent experimental evidence, and strategic guidance for translational researchers, highlighting new frontiers enabled by APExBIO’s Perphenazine (SKU B6157).

• iPSC Multilineage Organoids Enable Full Hepatitis E Virus Pr

  2026-05-12

  This study establishes induced pluripotent stem cell (iPSC)-derived multilineage liver, intestinal, and brain organoids as physiologically relevant models for hepatitis E virus (HEV) infection and replication. The platform advances virology research by supporting pan-genotype HEV propagation and elucidating tissue-specific pathogenic mechanisms, providing a robust alternative to existing in vitro and animal models.

• LDH Cytotoxicity Assay Kit in Advanced Nanocomposite Biocomp

  2026-05-11

  Explore how the LDH Cytotoxicity Assay Kit enables precise cell cytotoxicity measurement in cutting-edge nanocomposite research. This article uniquely connects quantitative assay selection to emerging insights from magnetic cellulose nanocrystal biocompatibility studies.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry:

  2026-05-11

  Wang et al. (2018) demonstrate that type III grass carp reovirus (GCRV104) enters kidney cells via clathrin-mediated, dynamin-dependent endocytosis, as revealed through systematic inhibitor studies. Their findings clarify the mechanistic basis of GCRV cellular entry, informing antiviral research and the strategic use of cytoskeletal inhibitors in related virological workflows.

• ABT-263 (Navitoclax): Redefining Apoptosis in Translational

  2026-05-10

  Explore the mechanistic depth and translational promise of ABT-263 (Navitoclax), a high-affinity Bcl-2 family inhibitor. This thought-leadership article integrates evidence from mitochondrial apoptosis research, strategic protocol guidance, and cross-study insights—empowering oncology researchers to design robust experiments and unlock new therapeutic paradigms.

• VX-745 in Precision Inflammation Research: Beyond Inhibition

  2026-05-09

  Explore how VX-745, a potent p38α MAPK inhibitor, enables precision modulation of inflammatory pathways. Discover new mechanistic insights and assay applications distinct from prior reviews.

• Efficient Synthesis of Deuterium-Labeled Degarelix Acetate:

  2026-05-09

  This study introduces an efficient, 13-step protocol for synthesizing deuterium-labeled degarelix acetate, a critical internal standard for pharmacokinetic and metabolic studies of androgen receptor antagonists. The work details key innovations in deuterium incorporation and peptide assembly, providing a robust foundation for both clinical and mechanistic research in metabolic and endocrine fields.

• Perphenazine: Dopamine D2 Receptor Antagonist in Advanced Re

  2026-05-08

  Perphenazine, a high-affinity dopamine D2 receptor antagonist, empowers neuropharmacology and host-pathogen studies with its unique dual action—inducing mitochondria-mediated cell death and enhancing macrophage antibacterial activity. Learn how APExBIO's rigorously characterized Perphenazine supports reproducible workflows, innovative assay design, and data-driven optimization.

• Photothermal Therapy and CD47 Blockade Synergy in OSCC

  2026-05-07

  The referenced study demonstrates that combining photothermal therapy with CD47 blockade significantly augments macrophage-mediated tumor clearance in oral squamous cell carcinoma. Mechanistically, this synergy is mediated by immunogenic cell death and extracellular matrix remodeling, offering a dual approach to overcoming immune evasion and physical barriers in solid tumors.

• SP600125 in JNK Pathway Research: Precision, Selectivity, an

  2026-05-07

  Explore the advanced scientific basis and unique assay optimization strategies enabled by SP600125, a highly selective JNK inhibitor. This article reveals new insights for apoptosis and inflammation research, building on recent kinase translation discoveries.

• Phenothiazines Enhance Macrophage Antibacterial Defenses via

  2026-05-06

  This study reveals that phenothiazines, including perphenazine, enhance macrophage antibacterial activity by inducing reactive oxygen species (ROS) and autophagy, offering a new host-directed strategy against intracellular pathogens. The findings clarify key mechanistic pathways, informing research on antimicrobial resistance and host-pathogen interactions.

• Neuroimaging Maturation of Dopamine Neurons in Parkinson’s M

  2026-05-06

  Goggi et al. (2020) demonstrate that dopamine transporter (DAT) neuroimaging can reliably assess the in vivo maturation of transplanted human embryonic stem cell-derived midbrain dopaminergic neurons in a preclinical model of Parkinson’s disease. This approach provides critical, non-invasive insights into cell therapy efficacy and dopaminergic neuron integration.

448 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page